Sun Pharmaceutical Industries wholly owned subsidiaries has launched generic metformin hydrochloride extended release tablets, used for glycemic control, in the US market.

The tablets are generic versions of Santarus Inc’s Glumetza HCl extended release tablets in the same strengths and have been launched in the strengths of 500 mg and 1000 mg. Further, the tablets are used to improve glycemic control in adults with type 2 diabetes.

Read EquityPandit’s Technical Analysis of Sun Pharma Outlook for the Week